Judy Chou, Ph.D., Appointed to Governing Board of California’s Stem Cell &...
October 3, 2022 South San Francisco, CA– Judy Chou, Ph.D. has been appointed to the Independent Citizens’ Oversight Committee (ICOC), the governing Board of the California Institute for Regenerative...
View ArticleCIRM Board Approves Funding for New Clinical Trial Targeting Brain Tumors
October 27th, 2022South San Francisco, CA– Today the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded almost $12 million to carry out a clinical trial targeting...
View ArticleStem Cell and Gene Therapy Agency Funds Clinical Trials Targeting Solid...
South San Francisco, CA– There were more than 24,500 kidney transplants in the US last year. The procedure can be life-saving but it also requires patients to take immune suppression medications to...
View ArticleStem Cell & Gene Therapy Agency Funds Clinical Trial to Make Cancer Therapy...
December 15, 2022 South San Francisco, CA – Blood stem cell transplantation following high dose chemotherapy is standard of care and potentially curative for aggressive forms of lymphoma. However, this...
View ArticleDr. Vito Imbasciani elected to serve as Chair of California stem cell agency
Dr. Vito Imbasciani will be the new Chair of the California Institute for Regenerative Medicine (CIRM), the state agency created by voters in 2004 and funded again in 2020 to invest in stem cell and...
View ArticleCalifornia stem cell and gene therapy agency investing in clinical trial for...
The governing Board of the California Institute for Regenerative Medicine (CIRM) voted to invest $15,637,174 in two projects in the agency’s Clinical program at its February meeting. These awards bring...
View ArticleCIRM welcomes new board Chair, invests $26 million in research
South San Francisco, CA —Dr. Vito Imbasciani was sworn in as the new Chair of the Board of the California Institute for Regenerative Medicine (CIRM). Imbasciani was elected to the six-year term at...
View ArticleClik here to view.
CIRM welcomes two additions to its leadership team
Left to right: Rafael Aguirre-Sacasa, General Counsel and Koren Temple-Perry, Senior Director of Marketing CommunicationsThe California Institute for Regenerative Medicine (CIRM) continues to build its...
View ArticleCIRM invests $89 million in stem cell and gene therapy research
The Board of the California Institute for Regenerative Medicine (CIRM) approved investing nearly $89 million in projects from its Clinical and Translation programs at its April meeting.Nearly $39...
View ArticleCIRM invests $10 million to build California Cell and Gene Therapy...
The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded $10 million to five facilities as part of the first phase to build...
View Article
